Cloverleaf Bio

Developing a new class of RNA therapeutics to revolutionize cancer therapy.

[Cloverleaf Bio @cloverleafbio]

Read the full release here: https://t.co/glbmJjx0PK

#tRNA #Therapeutics #Oncology #Biotech #SeedFunding #CancerResearch #DrugDevelopment

[Cloverleaf Bio @cloverleafbio]

Very excited to announce that we have closed a $33 Million seed round to advance a novel class of tRNA-based therapeutics for cancer.

[Cloverleaf Bio @cloverleafbio]

Thank you to everyone involved in this important milestone, we look forward to advancing our lead compounds toward the clinic.

[Cloverleaf Bio @cloverleafbio]

Led by @4biocapital , the oversubscribed round includes strategic investment from three major pharma venture arms, AbbVie Ventures, Eli Lilly and Company, and Boehringer Ingelheim Venture Fund, as well as @DraperVC , @MissionBioCap and @AmericanCancer

[Yale MB&B @YaleMBB]

Join us Friday, May 3rd at 2PM in Hope H-103 (or via zoom) for Cole Lewis' thesis defense titled "Maximizing Therapeutic Protein Yield Through 5' UTR Optimization"

[Yale Ventures @Yale_Ventures]

REVALIA BIO “HUMAN ORGAN RESEARCH” AWARD: 2023 @Yale Life Science Pitchfest

Wendy V. Gilbert (@WendyGScientist), PhD, Professor of Molecular Biophysics and Biochemistry

Project: Developing therapeutic tRNAs to revolutionize cancer therapy

[Cole Lewis @Cole_JT_Lewis]

1/ Super grateful to be named to the @ForbesUnder30 Healthcare class of 2024! I'm thrilled to be listed alongside such incredible young innovators, scientists, and entrepreneurs.
https://t.co/k4FhdrH46O

[Cloverleaf Bio @cloverleafbio]

You can meet with us and the other participating startups on 10.11 during a Networking Mixer
with MassBio's innovation ecosystem. Register here: https://t.co/PGSs3DEULS
the-massbiodrive-f23-cohort/ (3/3)